APO Research

APO RESEARCH · REPORT

AI Clinical Decision Support Software

Selected research

Market Outlook & Growth Opportunities

Global AI Clinical Decision Support Software Market Outlook and Growth Opportunities 2026

Market perspective

The global AI Clinical Decision Support Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Clinical Decision Support Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Clinical Decision Support Software market include Philips N.V., Siemens Healthineers AG, GE HealthCare Technologies Inc., Aidoc Medical Ltd., Viz.ai, Inc., Tempus AI, Inc., Flatiron Health, Inc., Dedalus S.p.A. and Fujitsu Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Clinical Decision Support Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Clinical Decision Support Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Clinical Decision Support Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Clinical Decision Support Software market.

AI Clinical Decision Support Software Segment by Company

Philips N.V.

Siemens Healthineers AG

GE HealthCare Technologies Inc.

Aidoc Medical Ltd.

Viz.ai, Inc.

Tempus AI, Inc.

Flatiron Health, Inc.

Dedalus S.p.A.

Fujitsu Limited

Yidu Tech Inc.

Winning Health Technology Group Co., Ltd.

Epic Systems Corporation

Wolters Kluwer N.V.

Elsevier B.V.

AI Clinical Decision Support Software Segment by Type

AI-Assisted Diagnostic Decision Support Software

AI Treatment Plan Recommendation Software

AI Medication Decision Support Software

AI Disease Risk Prediction Software

Others

AI Clinical Decision Support Software Segment by Application

Oncology

Cardiovascular Diseases

Neurological Disorders

Infectious Diseases

Chronic Disease Management

Others

AI Clinical Decision Support Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Clinical Decision Support Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Clinical Decision Support Software key companies, revenue, market share, and recent developments.

3. To split the AI Clinical Decision Support Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Clinical Decision Support Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Clinical Decision Support Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Clinical Decision Support Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Decision Support Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Decision Support Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Decision Support Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Decision Support Software industry.

Chapter 3: Detailed analysis of AI Clinical Decision Support Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Clinical Decision Support Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Clinical Decision Support Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Clinical Decision Support Software Industry Trends Table 2. AI Clinical Decision Support Software Industry Drivers Table 3. AI Clinical Decision Support Software Industry Opportunities and Challenges Table 4. AI Clinical Decision Support Software Industry Restraints Table 5. Global AI Clinical Decision Support Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Clinical Decision Support Software Revenue Share by Company (2021-2026) Table 7. Global AI Clinical Decision Support Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Clinical Decision Support Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Clinical Decision Support Software Company, Product Type & Application Table 10. Global AI Clinical Decision Support Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Clinical Decision Support Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of AI-Assisted Diagnostic Decision Support Software Table 15. Significant Companies of AI Treatment Plan Recommendation Software Table 16. Significant Companies of AI Medication Decision Support Software Table 17. Significant Companies of AI Disease Risk Prediction Software Table 18. Significant Companies of Others Table 19. Global AI Clinical Decision Support Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global AI Clinical Decision Support Software Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global AI Clinical Decision Support Software Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global AI Clinical Decision Support Software Sales Value Share by Type (2021-2026) Table 23. Global AI Clinical Decision Support Software Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Oncology Table 25. Significant Companies of Cardiovascular Diseases Table 26. Significant Companies of Neurological Disorders Table 27. Significant Companies of Infectious Diseases Table 28. Significant Companies of Chronic Disease Management Table 29. Significant Companies of Others Table 30. Global AI Clinical Decision Support Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Clinical Decision Support Software Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global AI Clinical Decision Support Software Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global AI Clinical Decision Support Software Sales Value Share by Application (2021-2026) Table 34. Global AI Clinical Decision Support Software Sales Value Share by Application (2027-2032) Table 35. Global AI Clinical Decision Support Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Clinical Decision Support Software Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global AI Clinical Decision Support Software Sales Value Share by Region (2021-2026) Table 38. Global AI Clinical Decision Support Software Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global AI Clinical Decision Support Software Sales Value Share by Region (2027-2032) Table 40. Global AI Clinical Decision Support Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global AI Clinical Decision Support Software Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global AI Clinical Decision Support Software Sales Value Market Share by Country (2021-2026) Table 43. Global AI Clinical Decision Support Software Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global AI Clinical Decision Support Software Sales Value Market Share by Country (2027-2032) Table 45. Philips N.V. Company Information Table 46. Philips N.V. Business Overview Table 47. Philips N.V. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Philips N.V. AI Clinical Decision Support Software Product Portfolio Table 49. Philips N.V. Recent Development Table 50. Siemens Healthineers AG Company Information Table 51. Siemens Healthineers AG Business Overview Table 52. Siemens Healthineers AG AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Siemens Healthineers AG AI Clinical Decision Support Software Product Portfolio Table 54. Siemens Healthineers AG Recent Development Table 55. GE HealthCare Technologies Inc. Company Information Table 56. GE HealthCare Technologies Inc. Business Overview Table 57. GE HealthCare Technologies Inc. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. GE HealthCare Technologies Inc. AI Clinical Decision Support Software Product Portfolio Table 59. GE HealthCare Technologies Inc. Recent Development Table 60. Aidoc Medical Ltd. Company Information Table 61. Aidoc Medical Ltd. Business Overview Table 62. Aidoc Medical Ltd. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Aidoc Medical Ltd. AI Clinical Decision Support Software Product Portfolio Table 64. Aidoc Medical Ltd. Recent Development Table 65. Viz.ai, Inc. Company Information Table 66. Viz.ai, Inc. Business Overview Table 67. Viz.ai, Inc. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Viz.ai, Inc. AI Clinical Decision Support Software Product Portfolio Table 69. Viz.ai, Inc. Recent Development Table 70. Tempus AI, Inc. Company Information Table 71. Tempus AI, Inc. Business Overview Table 72. Tempus AI, Inc. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Tempus AI, Inc. AI Clinical Decision Support Software Product Portfolio Table 74. Tempus AI, Inc. Recent Development Table 75. Flatiron Health, Inc. Company Information Table 76. Flatiron Health, Inc. Business Overview Table 77. Flatiron Health, Inc. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Flatiron Health, Inc. AI Clinical Decision Support Software Product Portfolio Table 79. Flatiron Health, Inc. Recent Development Table 80. Dedalus S.p.A. Company Information Table 81. Dedalus S.p.A. Business Overview Table 82. Dedalus S.p.A. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dedalus S.p.A. AI Clinical Decision Support Software Product Portfolio Table 84. Dedalus S.p.A. Recent Development Table 85. Fujitsu Limited Company Information Table 86. Fujitsu Limited Business Overview Table 87. Fujitsu Limited AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Fujitsu Limited AI Clinical Decision Support Software Product Portfolio Table 89. Fujitsu Limited Recent Development Table 90. Yidu Tech Inc. Company Information Table 91. Yidu Tech Inc. Business Overview Table 92. Yidu Tech Inc. AI Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Yidu Tech Inc. AI Clinical Decision Support Software Product Portfolio Table 94. Yidu Tech Inc. Recent Development Table 95. Winning Health Technology Group Co., Ltd. Company Information Table 96. Winning Health Technology Group Co., Ltd. Business Overview Table 97. Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Product Portfolio Table 99. Winning Health Technology Group Co., Ltd. Recent Development Table 100. Epic Systems Corporation Company Information Table 101. Epic Systems Corporation Business Overview Table 102. Epic Systems Corporation AI Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Epic Systems Corporation AI Clinical Decision Support Software Product Portfolio Table 104. Epic Systems Corporation Recent Development Table 105. Wolters Kluwer N.V. Company Information Table 106. Wolters Kluwer N.V. Business Overview Table 107. Wolters Kluwer N.V. AI Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Wolters Kluwer N.V. AI Clinical Decision Support Software Product Portfolio Table 109. Wolters Kluwer N.V. Recent Development Table 110. Elsevier B.V. Company Information Table 111. Elsevier B.V. Business Overview Table 112. Elsevier B.V. AI Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Elsevier B.V. AI Clinical Decision Support Software Product Portfolio Table 114. Elsevier B.V. Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. AI Clinical Decision Support Software Product Image Figure 2. Global AI Clinical Decision Support Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Clinical Decision Support Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Clinical Decision Support Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. AI-Assisted Diagnostic Decision Support Software Image Figure 8. AI Treatment Plan Recommendation Software Image Figure 9. AI Medication Decision Support Software Image Figure 10. AI Disease Risk Prediction Software Image Figure 11. Others Image Figure 12. Global AI Clinical Decision Support Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global AI Clinical Decision Support Software Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global AI Clinical Decision Support Software Sales Value Share by Type (2021-2032) Figure 15. Oncology Image Figure 16. Cardiovascular Diseases Image Figure 17. Neurological Disorders Image Figure 18. Infectious Diseases Image Figure 19. Chronic Disease Management Image Figure 20. Others Image Figure 21. Global AI Clinical Decision Support Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Clinical Decision Support Software Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global AI Clinical Decision Support Software Sales Value Share by Application (2021-2032) Figure 24. Global AI Clinical Decision Support Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global AI Clinical Decision Support Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America AI Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 27. North America AI Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe AI Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 29. Europe AI Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific AI Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific AI Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America AI Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 33. South America AI Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa AI Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa AI Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • AI-Assisted Diagnostic Decision Support Software
  • AI Treatment Plan Recommendation Software
  • AI Medication Decision Support Software
  • AI Disease Risk Prediction Software
  • Others
Applications
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Chronic Disease Management
  • Others
Companies covered
  • Philips N.V.
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Aidoc Medical Ltd.
  • Viz.ai, Inc.
  • Tempus AI, Inc.
  • Flatiron Health, Inc.
  • Dedalus S.p.A.
  • Fujitsu Limited
  • Yidu Tech Inc.
  • Winning Health Technology Group Co., Ltd.
  • Epic Systems Corporation
  • Wolters Kluwer N.V.
  • Elsevier B.V.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Clinical Decision Support Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Clinical Decision Support Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Clinical Decision Support Software Market Dynamics
  1. 2.1 AI Clinical Decision Support Software Industry Trends
  2. 2.2 AI Clinical Decision Support Software Industry Drivers
  3. 2.3 AI Clinical Decision Support Software Industry Opportunities and Challenges
  4. 2.4 AI Clinical Decision Support Software Industry Restraints
3 AI Clinical Decision Support Software Market by Company
  1. 3.1 Global AI Clinical Decision Support Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Clinical Decision Support Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Clinical Decision Support Software Company Ranking (2024-2026)
  4. 3.4 Global AI Clinical Decision Support Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Clinical Decision Support Software Company Product Type and Application
  6. 3.6 Global AI Clinical Decision Support Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Clinical Decision Support Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Clinical Decision Support Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Clinical Decision Support Software Market by Type
  1. 4.1 AI Clinical Decision Support Software Type Introduction
  2. 4.1.1 AI-Assisted Diagnostic Decision Support Software
  3. 4.1.2 AI Treatment Plan Recommendation Software
  4. 4.1.3 AI Medication Decision Support Software
  5. 4.1.4 AI Disease Risk Prediction Software
  6. 4.1.5 Others
  7. 4.2 Global AI Clinical Decision Support Software Sales Value by Type
  8. 4.2.1 Global AI Clinical Decision Support Software Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global AI Clinical Decision Support Software Sales Value by Type (2021-2032)
  10. 4.2.3 Global AI Clinical Decision Support Software Sales Value Share by Type (2021-2032)
5 AI Clinical Decision Support Software Market by Application
  1. 5.1 AI Clinical Decision Support Software Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiovascular Diseases
  4. 5.1.3 Neurological Disorders
  5. 5.1.4 Infectious Diseases
  6. 5.1.5 Chronic Disease Management
  7. 5.1.6 Others
  8. 5.2 Global AI Clinical Decision Support Software Sales Value by Application
  9. 5.2.1 Global AI Clinical Decision Support Software Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global AI Clinical Decision Support Software Sales Value by Application (2021-2032)
  11. 5.2.3 Global AI Clinical Decision Support Software Sales Value Share by Application (2021-2032)
6 AI Clinical Decision Support Software Regional Value Analysis
  1. 6.1 Global AI Clinical Decision Support Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Clinical Decision Support Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Clinical Decision Support Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Clinical Decision Support Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Clinical Decision Support Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Clinical Decision Support Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Clinical Decision Support Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Clinical Decision Support Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Clinical Decision Support Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
7 AI Clinical Decision Support Software Country-level Value Analysis
  1. 7.1 Global AI Clinical Decision Support Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Clinical Decision Support Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Clinical Decision Support Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Clinical Decision Support Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Philips N.V.
  2. 8.1.1 Philips N.V. Company Information
  3. 8.1.2 Philips N.V. Business Overview
  4. 8.1.3 Philips N.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Philips N.V. AI Clinical Decision Support Software Product Portfolio
  6. 8.1.5 Philips N.V. Recent Developments
  7. 8.2 Siemens Healthineers AG
  8. 8.2.1 Siemens Healthineers AG Company Information
  9. 8.2.2 Siemens Healthineers AG Business Overview
  10. 8.2.3 Siemens Healthineers AG AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers AG AI Clinical Decision Support Software Product Portfolio
  12. 8.2.5 Siemens Healthineers AG Recent Developments
  13. 8.3 GE HealthCare Technologies Inc.
  14. 8.3.1 GE HealthCare Technologies Inc. Company Information
  15. 8.3.2 GE HealthCare Technologies Inc. Business Overview
  16. 8.3.3 GE HealthCare Technologies Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GE HealthCare Technologies Inc. AI Clinical Decision Support Software Product Portfolio
  18. 8.3.5 GE HealthCare Technologies Inc. Recent Developments
  19. 8.4 Aidoc Medical Ltd.
  20. 8.4.1 Aidoc Medical Ltd. Company Information
  21. 8.4.2 Aidoc Medical Ltd. Business Overview
  22. 8.4.3 Aidoc Medical Ltd. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aidoc Medical Ltd. AI Clinical Decision Support Software Product Portfolio
  24. 8.4.5 Aidoc Medical Ltd. Recent Developments
  25. 8.5 Viz.ai, Inc.
  26. 8.5.1 Viz.ai, Inc. Company Information
  27. 8.5.2 Viz.ai, Inc. Business Overview
  28. 8.5.3 Viz.ai, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Viz.ai, Inc. AI Clinical Decision Support Software Product Portfolio
  30. 8.5.5 Viz.ai, Inc. Recent Developments
  31. 8.6 Tempus AI, Inc.
  32. 8.6.1 Tempus AI, Inc. Company Information
  33. 8.6.2 Tempus AI, Inc. Business Overview
  34. 8.6.3 Tempus AI, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tempus AI, Inc. AI Clinical Decision Support Software Product Portfolio
  36. 8.6.5 Tempus AI, Inc. Recent Developments
  37. 8.7 Flatiron Health, Inc.
  38. 8.7.1 Flatiron Health, Inc. Company Information
  39. 8.7.2 Flatiron Health, Inc. Business Overview
  40. 8.7.3 Flatiron Health, Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Flatiron Health, Inc. AI Clinical Decision Support Software Product Portfolio
  42. 8.7.5 Flatiron Health, Inc. Recent Developments
  43. 8.8 Dedalus S.p.A.
  44. 8.8.1 Dedalus S.p.A. Company Information
  45. 8.8.2 Dedalus S.p.A. Business Overview
  46. 8.8.3 Dedalus S.p.A. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dedalus S.p.A. AI Clinical Decision Support Software Product Portfolio
  48. 8.8.5 Dedalus S.p.A. Recent Developments
  49. 8.9 Fujitsu Limited
  50. 8.9.1 Fujitsu Limited Company Information
  51. 8.9.2 Fujitsu Limited Business Overview
  52. 8.9.3 Fujitsu Limited AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fujitsu Limited AI Clinical Decision Support Software Product Portfolio
  54. 8.9.5 Fujitsu Limited Recent Developments
  55. 8.10 Yidu Tech Inc.
  56. 8.10.1 Yidu Tech Inc. Company Information
  57. 8.10.2 Yidu Tech Inc. Business Overview
  58. 8.10.3 Yidu Tech Inc. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yidu Tech Inc. AI Clinical Decision Support Software Product Portfolio
  60. 8.10.5 Yidu Tech Inc. Recent Developments
  61. 8.11 Winning Health Technology Group Co., Ltd.
  62. 8.11.1 Winning Health Technology Group Co., Ltd. Company Information
  63. 8.11.2 Winning Health Technology Group Co., Ltd. Business Overview
  64. 8.11.3 Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Winning Health Technology Group Co., Ltd. AI Clinical Decision Support Software Product Portfolio
  66. 8.11.5 Winning Health Technology Group Co., Ltd. Recent Developments
  67. 8.12 Epic Systems Corporation
  68. 8.12.1 Epic Systems Corporation Company Information
  69. 8.12.2 Epic Systems Corporation Business Overview
  70. 8.12.3 Epic Systems Corporation AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Epic Systems Corporation AI Clinical Decision Support Software Product Portfolio
  72. 8.12.5 Epic Systems Corporation Recent Developments
  73. 8.13 Wolters Kluwer N.V.
  74. 8.13.1 Wolters Kluwer N.V. Company Information
  75. 8.13.2 Wolters Kluwer N.V. Business Overview
  76. 8.13.3 Wolters Kluwer N.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Wolters Kluwer N.V. AI Clinical Decision Support Software Product Portfolio
  78. 8.13.5 Wolters Kluwer N.V. Recent Developments
  79. 8.14 Elsevier B.V.
  80. 8.14.1 Elsevier B.V. Company Information
  81. 8.14.2 Elsevier B.V. Business Overview
  82. 8.14.3 Elsevier B.V. AI Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Elsevier B.V. AI Clinical Decision Support Software Product Portfolio
  84. 8.14.5 Elsevier B.V. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research